Beijing Scitop Bio-tech Co Ltd Class A 300858
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥15.28
- Day Range
- ¥15.32–17.24
- 52-Week Range
- ¥13.20–21.41
- Bid/Ask
- ¥17.01 / ¥17.02
- Market Cap
- ¥4.48 Bil
- Volume/Avg
- 6.3 Mil / 1.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 46.30
- Price/Sales
- 13.39
- Dividend Yield (Trailing)
- 0.98%
- Dividend Yield (Forward)
- 0.98%
- Total Yield
- 0.98%
Company Profile
Beijing Scitop Bio-tech Co Ltd is engaged in production and sales of compound food additives, edible probiotic products and animal and plant micro-ecological preparations. The company engages in provision of biotechnology services, consulting, development, transfer; development and sale of stereotyped packaged food additives, compound food additives. Its products include Probio-M8 and Probio-M9.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 330
- Website
- http://www.scitop.cn
Comparables
Valuation
|
Metric
|
300858
|
688098
|
603566
|
|---|---|---|---|
Price/Earnings (Normalized) | 46.30 | — | 45.35 |
Price/Book Value | 2.32 | 1.21 | 1.71 |
Price/Sales | 13.39 | 5.01 | 4.10 |
Price/Cash Flow | 51.74 | 33.50 | 18.33 |
Price/Earnings
300858
688098
603566
Financial Strength
|
Metric
|
300858
|
688098
|
603566
|
|---|---|---|---|
Quick Ratio | 6.91 | 5.14 | 2.23 |
Current Ratio | 12.85 | 6.45 | 2.70 |
Interest Coverage | 162.38 | — | 944.40 |
Quick Ratio
300858
688098
603566
Profitability
|
Metric
|
300858
|
688098
|
603566
|
|---|---|---|---|
Return on Assets (Normalized) | 4.81% | −0.90% | 3.00% |
Return on Equity (Normalized) | 5.01% | −0.96% | 3.58% |
Return on Invested Capital (Normalized) | 3.65% | −1.00% | 3.44% |
Return on Assets
300858
688098
603566
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Lhpqtwldg | Dskn | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Khcstzz | Hcwsvqv | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Tzdrbdpx | Trycjh | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Yhjwrzh | Xyftdf | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Dtpbpvlqz | Nlgm | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Gxytpvyc | Bkgq | $28.1 Bil | |||
| Moderna Inc
MRNA
| Bdfbkkb | Lmft | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Blcpsgyjv | Dmfys | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hjwddwd | Sycntm | $13.4 Bil | |||
| Incyte Corp
INCY
| Rywsrwjc | Nkrlgg | $12.7 Bil |
United States